Topic search: DOSAGE FORMS/DRUG CARRIERS

Search the Journal's archive for all articles tagged as being related to your selected topic. Click here to return to the list of all topics.

Refine your search by entering keywords here:

Dosage Forms and Drug Carrier Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2025 Pg. 279-290	Stability Study of Pediatric Oral Suspensions Formulated with PCCA SuspendIt Vehicle Used for the Treatment of Cardiovascular Disease Author(s): Davis Courtaney, Ip Kendice, Banov Daniel, Zdoryk Oleksandr
Jul/Aug 2025 Pg. 310-318	Antimicrobial Stability, pH, and Physical Appearance of Cardiovascular Drug Suspensions in SyrSpend® SF PH4: A Complementary Evaluation Author(s): Kegele Carolina Schettino, Dijkers Eli, Polonini Hudson
Jul/Aug 2025 Pg. 319-327	Antimicrobial Effectiveness and Physicochemical Stability of Compounded Psychiatric and Neurological Drug Suspensions in SyrSpend® SF PH4 Author(s): Kegele Carolina Schettino, Dijkers Eli, Polonini Hudson
Mar/Apr 2025 Pg. 150-162	Compatibility of Active Pharmaceutical Ingredients Combinations Compounded in Cleoderm™, a Cream Base for Personalized Dermatological Treatments Author(s): Marianni Bruna, Silva Carolina Costa Vicente, Polonini Hudson
Mar/Apr 2025 Pg. 163-175	Assessing the Compatibility of Different Formulations in OrPhyllo™, A Ready-to-Use Base for Personalized Orodispersible Films Author(s): Marianni Bruna, Polonini Hudson, Koulouridas Savvas
Jan/Feb 2025 Pg. 14-21	K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study Author(s): Kumaravelrajan Rajagopal, Arockiyasamy Kishore metha, Venkatesan Suba, Thiraviam Purushoth Prabhu
Jan/Feb 2025 Pg. 40	Calculations - Salicylic Acid Ointments - Percent Strength of a Semisolid Dosage Form, Alligation Alternate Method of Calculation, Temperature Conversion Author(s): Stockton Shelly J
Nov/Dec 2024 Pg. 460-467	Extemporaneous Compounding of Medicated Ointments Author(s): Nagel Karen, Ali Fatima, Al-Khudari Sarah, Khan Ayesha, Patel Khushbu, Patel Nikunj, Desai Archana
Sep/Oct 2024 Pg. 358-362	Pharmaceutical Waters Used in Sterile and Nonsterile Compounding Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 296-297	Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 194-204	Compounding and Characterization of a Selfmicroemulsifying System of Ticagrelor Tablets for Enhanced Solubility Author(s): Kumaravelrajan Rajagopal, Naresh Narayanan, Mohanta Guru Prasad, Venkatesan Suba, Prasad Pasupuleti Dharani
May/Jun 2024 Pg. 226-227	Recommended Tips for Treating Veterinary Patients Author(s): Bramwell Bethany L, Williams LaVonn A
May/Jun 2024 Pg. 243	Carprofen 2.5-mg/mL Oral Suspension, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 244	Diltiazem 5% in Lipoderm, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 245	Miconazole 1% Ophthalmic Solution, Veterinary Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 94-98	Magic Mouthwashes- A Literature Review and Discussion of Common Compositions Author(s): McElhiney Linda F
Mar/Apr 2024 Pg. 100-109	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024 Pg. 118-119	Safe Use of Topical Local Anesthetic Medications for Pain Management Author(s): Epshteyn Mikhail G, Pepin Steven M
Mar/Apr 2024 Pg. 130	Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel GEL Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 132	Analgesic Compound Lotion, Clear Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 133	Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 134	Diclofenac Sodium 1% Soft-patch Gel Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 135	Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 138-145	Hydrophilic Ready-to-use Vehicles and Compounded Topical Medications Author(s): Spennacchio Antonio, Lacassia Chiara, Lopalco Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Franco Massimo, Denora Nunzio
Mar/Apr 2024 Pg. 146-150	Lipophilic Ready-to-use Vehicles and Compounded Topical Medications Author(s): Lacassia Chiara, Spennacchio Antonio, Lopalco Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Franco Massimo, Denora Nunzio
Mar/Apr 2024 Pg. 151-155	Physical-chemical Stability of the Extemporaneous Paracetamol Oral Suspension in Puccini Base Author(s): Lacassia Chiara, Spennacchio Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Denora Nunzio, Lopalco Antonio
Mar/Apr 2024 Pg. 156-160	Stability Evaluation of Bracketed Diclofenac Sodium USP in VersaPro™ Cream Base, VersaPro™ Gel Base and PLO Gel Mediflo™ 30 Compound Kit Author(s): Friciu Mihaela, Cull Erica, Haiub Halema, Lupatini Rodrigo, Leclair Grégoire
Mar/Apr 2024 Pg. 169-175	Clinical Safety Profile of TrichoConcept™, a Line of Cosmetic Vehicles for Personalized Treatment of Alopecia Author(s): Marianni Bruna, Polonini Hudson, Silva Carolina
Jan/Feb 2024 Pg. 6-14	Treatment Options for Male Hypogonadism Author(s): Biundo Bruce
Jan/Feb 2024 Pg. 16-21	The Physiologic Role and Use of Estriol Author(s): Paoletti Jim E
Jan/Feb 2024 Pg. 28-32	Hormone Treatment Options for Males: What to do for Men with Low Testosterone Author(s): Biundo Bruce
Jan/Feb 2024 Pg. 58	Estradiol 0.1% Vaginal Solution Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 474-481	Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 488	Calculations Author(s): Stockton Shelly J
Nov/Dec 2023 Pg. 490	Curcumin 1% Intranasal Mucoadhesive Gel Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 492	Hydrocortisone 2% and Menthol 0.5% in VersaPro Cream Base Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 493	Salicylic Acid 30% Gel Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 494-502	Pathophysiology and Management of Onychomycosis and Novel Approaches for Effective Transdermal Applications Author(s): Dharmian Jose Prakash, Sathiyaseelan Iraniammal, Renganathan Akshaya, Mubees Alamaan Mohamed, Naser Mohammed Yasin Abdul, Ramkrishnan Prakash, Arumugam Somasundaram
Nov/Dec 2023 Pg. 512-521	Compounding and Characterization of Oral Disintegrating Films Containing Memantine Hydrochloride for Geriatrics Author(s): Rofiq Hanifah Mohd, Phang Hiu Ching, Janakiraman Ashok Kumar, Chew Yik-Ling, Uddin ABM Helal, Sarker Zaidul Islam, Lee Siew-Keah, Liew Kai Bin
Nov/Dec 2023 Pg. 522-527	Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet Author(s): Hazdi Siti Nursaqifah, Phang Hiu Ching, Ng Zhi Qi, Chew Yik Ling, Uddin ABM Helal, Sarker Zaidul Islam, Lee Siew-Keah, Liew Kai Bin
Sep/Oct 2023 Pg. 362-366	Compounding Metformin for Use in Functional Medicine Author(s): Desai Sarina, Thompson Tara
Sep/Oct 2023 Pg. 386-395	Basics of Compounding: Compounding Foams Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 412	Crotamiton 10% Cream Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 414-415	Fluconazole 1% Thermoresponsive Gel Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 417	Idoxuridine 5% in Dimethyl Sulfoxide Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 421	Povidone Iodine Lotion Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 424-430	Evaluation of Compounded Transdermal Analgesic Formulations Using the Franz Finite Dose Model Author(s): Baneshi Marzieh, Tyagi Deependra, Panneerselvam Ezilrani, MacKenzie Graham, Coleman Johngary, Zhang Shine X
Jul/Aug 2023 Pg. 278-283	Topical Vehicles: A Dermatologist's Perspective Author(s): Adame Stephanie, Collins Michael E, Korman Abraham M
Jul/Aug 2023 Pg. 316	Chlorhexidine and Cetrimide Lotion Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 317-318	Clobazam 5-mg/mL Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 319	Clotrimazole 1% and Betamethasone Dipropionate 0.05% Cream Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 320-321	Cyclosporine Topical Gel Formulation Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 324-325	Levofloxacin 0.5% Topical Gel Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 326	Losartan Potassium 2.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 327	Nystatin Oromucosal Gel Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 340-346	Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System Author(s): Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
May/Jun 2023 Pg. 182-190	Warts: Pathophysiology, Types, Treatments, and Pharmaceutical Compounds Author(s): Touprong Robin, Thompson Tara, Williams LaVonn A
May/Jun 2023 Pg. 218-221	Nonsterile Basics of Compounding: Compounding with Humectants Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 230-231	Calculations Author(s): Stockton Shelly J
May/Jun 2023 Pg. 232-233	Acetaminophen 500-mg/mL Rectal Solution Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 235	Gentamicin 480-mg/1000-mL Bladder Irrigation Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 237	Migraine Headache Suppositories Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 238	Nifedipine, Lidocaine, and Nitroglycerin Suppositories Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 240-249	An Alternative Approach to Tablet Splitting and Grinding for Medication Administration Author(s): Taneja Rajneesh, Scarim Joseph, Pande Poonam G, Scarim Anthony, Nahata Milap C, Jew Rita K, Inabathina Koteswara Rao
May/Jun 2023 Pg. 256-262	Extemporaneous Topical Minoxidil Solutions for the Treatment of Alopecia: Stability Studies and Incorporation Tests of Active Ingredients in ALOPLUS FAST Base Author(s): Spennacchio Antonio, Lopedota Angela Assunta, Lopalco Antonio, Dibenedetto Maria Teresa, la Forgia Flavia Maria, Fontana Sergio, Franco Massimo, Denora Nunzio
Mar/Apr 2023 Pg. 92	PreScription: Amoxicillin Shortage Continues: Compounding Pharmacies Filling the Gap! Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 108-112	Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study Author(s): Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana
Mar/Apr 2023 Pg. 143	Amphotericin B 0.1% Topical Microemulsion Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 144	Aphthous Ulcer Gel Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 146	Cyclosporine Topical Microemulsion Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 147	Hypochlorous Acid 0.01% Oral Rinse Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 148	Nystatin, Lidocaine, Hydrocortisone, and Chlorhexidine Oral Rinse Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 153	Timolol 0.125%/Mucolox 15%/0.9% Normal Saline Nasal Spray Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 6-10	Case Report of Anal Fissures and Hemorrhoids Treated with Compounded Cromolyn Sodium and Naltrexone Hydrochloride in MEDISCA's SPG SUPPOSI-BASE Author(s): Earlywine Kerry, Haiub Halema, Cull Erica, Lupatini Rodrigo, Sidhu Raman
Jan/Feb 2023 Pg. 24-29	Basics: A Review: In Situ Gel Dosage Forms for Herbal Medicine Delivery Author(s): Rachmawati Putriana
Jan/Feb 2023 Pg. 30-37	Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 50	Acetaminophen 10 mg/mL for Rectal Use Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 51	Clozapine 20 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 52	Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 53	Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 54	Manning's Liniment Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 55	Mayer's Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 56	Povidone Iodine 100-mg/mL Solution/Spray Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 57	Psoriasis Topical Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 58-59	Suspension Solution, Sugar Free Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 468-472	Unlicensed Transdermal Medications in Feline Patients: Three Case Reports Author(s): Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael
Nov/Dec 2022 Pg. 480-488	A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing Author(s): Riepl Mike
Nov/Dec 2022 Pg. 490-495	Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 508	Bacitracin 0.01% and Phenol 0.1% in Cetaphil Lotion Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 509	Curcumin 2% Topical Gel Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 516-521	Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage Author(s): Kumaravelrajan Rajagopal, Karthik B, Venkatasan Suba
Sep/Oct 2022 Pg. 356	PreScription: A New Dosage Form Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 370-377	Recent Formulation Advances and Preparation of Orally Disintegrating Tablets Author(s): Ejeta Fikadu
Sep/Oct 2022 Pg. 420	Calculations Author(s): Stockton Shelly J
Sep/Oct 2022 Pg. 422	Amphotericin B 3% Otic Gel Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 426	Clotrimazole 10-mg Troches Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 436-439	Effects of Calcium Polystyrene Sulfonate Formulation Change from Dry Syrup to Oral Solution in Patients with Chronic Kidney Disease Author(s): Kobayashi Shunsuke, Ogawara Yuka, Imamura Yoshihiko, Kitaoka Akira, Yasu Takeo
Jul/Aug 2022 Pg. 270-274	A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline Author(s): Riepl Mike
Jul/Aug 2022 Pg. 283-291	Evaluation of the Physical-chemical Characteristics and Biopharmaceutical Performance of Dilu-Cap: A Complete Line of Excipients for Hard-shell Capsules Author(s): de Oliveira Ferreira Anderson, Polonini Hudson
Jul/Aug 2022 Pg. 302-307	Basics: Hollow-type Suppositories Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 318	Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Lotion Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 320	Dexamethasone 1 mg/mL in Oral Mix Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 325-326	Indomethacin 1% Topical Gel Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 327	Nystatin 250,000-unit Frozen Popsicles Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 328	Povidone Iodine 100-mg/mL Solution/Spray Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 330-335	Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes Author(s): Bartoll Aaron Puplà, Bellés Medall Maria Dolores, Peñarrocha Josep Edo, Escrig Laura Solaz, Clemente Ruben Eguren, Azuara Julia Bodega, Piqueres Raul Ferrando
Jul/Aug 2022 Pg. 336-341	Long-term Stability of Epitheliotropic Factors in Frozen Serum Eye Drops Author(s): Sahyoun Jean-Yves, Cloutier Marc, Frenette Mathieu, Robert Marie-Claude
May/Jun 2022 Pg. 189-193	A Compendium of Compounding Agents and Formulations, Part 3: Gentamicin Sulfate and Benzoyl Peroxide Author(s): Riepl Mike
May/Jun 2022 Pg. 195-200	A Procedure for Tablet Production by Using the 3D Molding Technology and Powder Micromeritics Properties Author(s): Mady Omar
May/Jun 2022 Pg. 214-217	Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 232	Alendronate Sodium 1% Topical Dental Gel Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 233	Azstarys in Ora-Blend Single Dose Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 240	Sirolimus 0.1% Ointment Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 255-263	Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets Author(s): Liew Kai Bin, Hii Shou Hui, Chew Yik Ling, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam
Mar/Apr 2022 Pg. 92	PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry" Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 94-98	A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin Author(s): Riepl Mike
Mar/Apr 2022 Pg. 110-115	The Potential Effects of a Compounded Methylcobalamin Nasal Spray on Short-term Memory Loss After Intracranial Hemorrhage: A Case Report Author(s): Good Lauren, Lieu Yi, Banov Fabiana, Harger Beau, Banov Daniel
Mar/Apr 2022 Pg. 118-126	Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 140	Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 141	Codeine Phosphate 3 mg/mL in Ora-Sweet Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 142	Ketoconazole 2%, Terbenafine 1%, Acetic Acid 2%, and Urea 2% in Dimethyl Sulfoxide Nail Polish Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 143	Lorazepam 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 144	Mesalamine 100-mg/mL Suspension Enema Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 145	Naproxen 25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 146	Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 147	Phenytoin 15 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 149	Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 150-154	Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates) Author(s): Brandin Thibaut, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice
Mar/Apr 2022 Pg. 155-162	Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate Author(s): Ruslan Mohamad Fariz Haiqal, Janakiraman Ashok Kumar, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
Mar/Apr 2022 Pg. 163-174	Molding as Innovative Technology for Personalized Tablet Production Author(s): Mady Omar Y, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A
Jan/Feb 2022 Pg. 6-8	Compounded Melatonin Cream for the Prevention and Treatment of Radiation Dermatitis: A Case Report Author(s): Garcia-Segura Laura Corral, Garcia-Segura Javier Corral, Delgado Carlos Dorado, Maldonaldo Nuria Romero, Salgado Elena Cardero, Llorens Lucía Pérez
Jan/Feb 2022 Pg. 18-23	A Compendium of Compounding Agents and Formulations, Part 1: Melatonin Author(s): Riepl Mike
Jan/Feb 2022 Pg. 34-38	Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 52	Aluminum Chloride 6.25% in Anhydrous Alcohol Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 53	Ascorbic Acid 10% in Anhydrous PEG ointment Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 54	Deoxyarbutin 3% Anhydrous Emulsion Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 55	Diclofenac Sodium 1%-15% Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 57	Mometasone Furoate 0.1% Lotion Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 65-71	Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management Author(s): Hong Eun Ji, Sumanasekera Wasana, Le Uyen Minh
Jan/Feb 2022 Pg. 80-87	Investigation of the Effects of Excipients in the Compounding of Amlodipine Besylate Orally Disintegrating Tablets Author(s): Azmi Nurual Hanisah Saiful, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
Nov/Dec 2021 Pg. 464-467	Glycopyrrolate Sorbitol Lollipops for Drooling: Two Case Reports Author(s): Agbi Kelechi E, Carvalho Maria, Vieira-Banov Fabiana
Nov/Dec 2021 Pg. 468-472	Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 4. Insulin Author(s): Riepl Mike
Nov/Dec 2021 Pg. 482-485	Case Reports on the Use of Aloe Vera, Naltrexone, and Topiramate for the Treatment of Scars Author(s): Harris Kylie, Wright Edward
Nov/Dec 2021 Pg. 500	Domperidone 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 501	Kayexalate in Lactulose Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 502	Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 503	Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 504	Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 508	Sulfadiazine 100 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 509	Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 523-527	Formulation, Physical Stability, and the Clinical Effectiveness of Extemporaneous Ivermectin Oral Solution Author(s): Zaid Abdel-Naser, Zaaror Yara Abu, Qaddumi Aiman, Ratrout Ala, Ahmad Ayda, Hamad Emad, Kittana Naim
Sep/Oct 2021 Pg. 364-371	Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products Author(s): Uttaro Elizabeth, Zhao Fang, Schweighardt Anne
Sep/Oct 2021 Pg. 372-377	Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Author(s): Riepl Mike
Sep/Oct 2021 Pg. 422-426	Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application Author(s): Polonini Hudson, de Oliveira Ferreira Anderson, Dijkers Eli
Sep/Oct 2021 Pg. 427-430	Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base Author(s): Lopalco Antonio, Lopedota Angela, Aurelio Fiorenza, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Jul/Aug 2021 Pg. 282-287	Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2 Author(s): Riepl Mike
Jul/Aug 2021 Pg. 304-309	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 320	Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 321	Atomoxetine 4-mg/mL Oral Solution/Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 322	BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel) Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 323	Budesonide 0.0.25% Mucoadhesive Gel Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 324	Cyclopentolate Hydrochloride 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 325	Hydrocortisone 2-mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 326	Moh's Paste, Modified Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 327	Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 328	Tacrolimus 0.1% Topical Microemulsion Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 329	Valsartan 4-mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 336-343	Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base Author(s): Polonini Hudson C, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah
Jul/Aug 2021 Pg. 344-351	Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U
May/Jun 2021 Pg. 218-221	Basics of Compounding: Excipients Used in Nonsterile Compounding: Diluents Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 236-240	Stability Evaluation of Minoxidil in FOAMIL Foam Base with Bracketing Study Design Author(s): Lupatini Rodrigo, Sidhu Raman, Patel Harshad, Bichar Katia
May/Jun 2021 Pg. 241-245	In Vitro Release Tests of Ketoprofen from Pluronic Lecithin Organogel versus Lipoderm Using Immersion Cells and the Phoenix DB-6 Dry Heat Diffusion Tester Author(s): McKinney Rachael D, Dunbar Jacob R
Mar/Apr 2021 Pg. 94-98	The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report Author(s): McKettrick Greg, Yoch Doug
Mar/Apr 2021 Pg. 100-103	Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing Author(s): Riepl Mike
Mar/Apr 2021 Pg. 126-128	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 8: Humectants Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 142	Amlodipine 1-mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 143	Canine Soft Chew Base (Veterinary) Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 144	Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 145	Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 146-155	In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%) Author(s): Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
Mar/Apr 2021 Pg. 163-168	Stability of Extemporaneously Compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes Author(s): Walsh Andrea, Ziegler Blake, Lingertat-Walsh Karen, Law Shirley, Walker Scott E
Mar/Apr 2021 Pg. 169-175	Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
Jan/Feb 2021 Pg. 48-51	Design and Performance of an Inexpensive Water Activity Meter Author(s): Gilda Sagar S, Schober Joseph M, McPherson Timothy
Jan/Feb 2021 Pg. 82-87	Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving Tablets Author(s): Cheung Matthew, Zhao Fang, Dave Vivek S
Nov/Dec 2020 Pg. 446-448	NASEM Report on Compounded Topical Pain Creams Author(s): Allen Loyd V Jr
Nov/Dec 2020 Pg. 482-490	Stability of Compounded Diltiazem Hydrochloride in Cream, Ointment, and Gel Formulations for Topical Use Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U
Nov/Dec 2020 Pg. 491-500	Analysis of Extemporaneously Compounded Nasal Preparations Prescribed by Latvian Otorhinolaryngologists and General Practitioners and Comparison with German Formulations Author(s): Kiselova Olga, Maurina Baiba, Sidlovska Venta
Nov/Dec 2020 Pg. 501-508	Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U
Nov/Dec 2020 Pg. 509-514	Investigation of Filler Effects on the Compounding of Freeze-dried Orodispersible Tablets Containing Annona muricata Extract Author(s): Azman Syahiera Ezzah Noor, Abd Razak Fashli Syafiq, Kamal Wan Hamirul Bahrin Wan, Zheng Gan Kok, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
Nov/Dec 2020 Pg. 515-518	Development and Evaluation of an Anti-aging Cosmetic Formulation Exploring Antioxidant Potential of Vitis vinifera L. Author(s): Carneiro Jaqueline, Marques Gonçalves Melissa, Vicente Pereira Airton
Nov/Dec 2020 Pg. 519-527	Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure Author(s): Ma Nathan, Perks William, Law Shirley, Iazzetta John, Walker Scott
Sep/Oct 2020 Pg. 367-369	Topical Cholesterol/Simvastatin Gel for the Treatment of CHILD Syndrome in an Adolescent Author(s): Cho Sung Kyung, Ashworth Lisa Diggs, Goldman Shauna
Sep/Oct 2020 Pg. 388-395	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 7: Compounding with Surfactants Author(s): Allen Loyd V Jr
Sep/Oct 2020 Pg. 407	Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2020 Pg. 408-412	Always the Right Dose? Content Uniformity in Over 100 Different Formulations Tested Author(s): Dijkers Eli, Polonini Hudson, de Oliveira Ferreira Anderson
Sep/Oct 2020 Pg. 413-419	Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
Jul/Aug 2020 Pg. 278-281	Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2 Author(s): Riepl Mike
Jul/Aug 2020 Pg. 282-285	Compounding Pearls -- Wound Care: Burn Healing, Part 2 Author(s): Riepl Mike
Jul/Aug 2020 Pg. 313	Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 337-345	Evaluation of the Efficacy and Stability of Compounded Pentoxifylline-containing XemaTop for Psoriasis Author(s): Song Guiyun, Ip Kendice, Shan Ashley, Banov Daniel, Bassani August S
May/Jun 2020 Pg. 182-186	Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1 Author(s): Riepl Mike
May/Jun 2020 Pg. 188-193	Compounding Pearls -- Wound Care: Burn Healing, Part 1 Author(s): Riepl Mike
May/Jun 2020 Pg. 194-197	Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality Author(s): Hagan John C III, Everett Eric, Chamberlain Tyler
May/Jun 2020 Pg. 242-245	Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture Author(s): Ngim Kenley, Patel Jalpa
Mar/Apr 2020 Pg. 104-108	Low-dose Pilocarpine Spray to Treat Xerostomia Author(s): Zur Eyal
Mar/Apr 2020 Pg. 128	Calculations Author(s): Stockton Shelly J
Mar/Apr 2020 Pg. 140-147	The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment Author(s): Meissner Svenja, Bansal Mahima, Dela Cruz Paula Donamae, Hanning Sara, Svirskis Darren
Mar/Apr 2020 Pg. 148-155	Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets Author(s): Mahesparan Vishnu A/L, Bin Abd Razak Fashli Syafiq, Ming Long Chiau, Uddin ABM Helal, Sarker Md Zaidul Islam, Bin Liew Kai
Mar/Apr 2020 Pg. 163-167	Feasibility Study of Asthma Cream Author(s): Kuang Andrew
Mar/Apr 2020 Pg. 168-175	Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel Author(s): Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
Jan/Feb 2020 Pg. 57	Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 59	LCD 5%, Salicylic Acid 6% in Clobetasol Propionate 0.05% Ointment Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 472-477	Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 496-503	Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy? Author(s): Shakshuki Ayah, Agu Remigius U
Sep/Oct 2019 Pg. 366-375	Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3 Author(s): Zur Eyal
Sep/Oct 2019 Pg. 376-381	Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus Author(s): Zur Eyal
Sep/Oct 2019 Pg. 393-396	Basics: Excipients Used in Nonsterile Compounding, Part 2 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 399-402	Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 288-293	Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2 Author(s): Zur Eyal
Jul/Aug 2019 Pg. 325-339	Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy Author(s): Glaser Rebecca L, York Anne E
May/Jun 2019 Pg. 211-216	Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 1: Physical and Chemical Testing Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 245-249	Trends of Extemporaneous Drug Prescription in Latvia in 2017 Author(s): Kiselova Olga, Maurina Baiba, Sidlovska Venta, Rogovska Irena
May/Jun 2019 Pg. 250-257	Compounding and Comparative Study of a Superior, Faster, and More Adaptable Lidocaine Dental Gel Formulation Author(s): Rashid Mamoon, Hossain Mohammad Faisal, Nounou Mohamed, Rahman Mehbuba, Sarkar Sushanta, Adeyemo Akinola, Mullins Randy
Mar/Apr 2019 Pg. 94-104	Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Author(s): Zur Eyal
Mar/Apr 2019 Pg. 113-119	Penfluridol, a Unique Psychiatric Medicine for the Treatment of Chronic Schizophrenia Author(s): Zur Eyal
Mar/Apr 2019 Pg. 149	Dexamethasone 2 mg/g Topical Paste, Veterinary Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 150	Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 23-31	Topical Treatment of Primary Focal Hyperhidrosis, Part 1 Author(s): Zur Eyal
Jan/Feb 2019 Pg. 52	Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 54	Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide–Magnesium Hydrochloride–Simethicone Mouthwashes Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 59	Orodispersible Film Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 65-69	Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle Author(s): Polonini Hudson, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
Jan/Feb 2019 Pg. 77-81	Ex Vivo Evaluation of Intravaginal Progesterone and Testosterone to Treat the Luteal-phase Deficiency and Vaginal Atrophy Author(s): Laque Larissa C, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson, Polonini Hudson C
Jan/Feb 2019 Pg. 82-87	Stability Assessment of Topical Amitriptyline Extemporaneously Compounded with Lipoderm Base, PLO Gel Mediflo 30, and Emollient Cream Author(s): Shakshuki Ayah, Agu Remigius U
Nov/Dec 2018 Pg. 466-468	Case Study: Absorption of Testosterone Cream via Scrotal Delivery Author(s): Needham Shawn, Needham Shane
Nov/Dec 2018 Pg. 480-489	Basics of Compounding: Vehicles for Compounded Oral Liquid Medications: A Review Author(s): Cutaia Kara, Chablani Lipika, Zhao Fang
Nov/Dec 2018 Pg. 490	Calculations Author(s): Stockton Shelly J
Nov/Dec 2018 Pg. 512-515	Compounded Orodispersible Films with Natural Ingredients for Halitosis: A Clinical Experience Author(s): Apolinário Régis De Souza, Chaves Maria Das Graças Afonso Miranda, Gonçalves Hanny Reis Mockdeci, Martins Isadora Conde Ferreria, De Paula Renée Mazilão, Granato Ana Paula Alves, Polonini Hudson Caetano, Brandão Marcos Antônio Fernandes, Ferreira Anderson De Oliveira, Raposo Nádia Rezende Barbosa
Nov/Dec 2018 Pg. 516-526	Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Sep/Oct 2018 Pg. 408	Cysteamine 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 409	Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 412-416	Stability of Tranexamic Acid Mouth Rinse Author(s): Donnelly Ronald F
Jul/Aug 2018 Pg. 294-300	Basics of Compounding--Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 2 Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 316	Anhydrous Medium-chain Triglycerides Gel Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 317	Budesonide 1-mg//10-mL Mucolox Oral Suspensions Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 182-188	Pitch Ointment: Applications in Scar and Wound Management Author(s): Kloesel Lawson, Carvalho Maria, Banov Fabiana
May/Jun 2018 Pg. 196-202	Case Report of a Human Papillomavirus Infection Treated with Green Tea Extract and Curcumin Vaginal Compounded Medications Author(s): Agbi Kelechi E, Hover Sara, Carvalho Maria
May/Jun 2018 Pg. 220-228	Basics of Compounding–Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 1 Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 230	Calculations Author(s): Stockton Shelly J
May/Jun 2018 Pg. 232	Anhydrous Silicon Base Topical Gel Vehicle Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 233	Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 235	Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 236	Pyrimethamine 2 mg/mL in Ora-Plus and Ora-Sweet Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 237	Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 238	Simvastatin 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 239	Trimethoprim 20 mg/mL and Sulfadiazine 100 mg/mL in Suspendit Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 108-121	Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management Author(s): Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Mar/Apr 2018 Pg. 137-143	Basics of Compounding: Compounding Microemulsions Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 154-163	Evaluation and Comparison of Wound Healing Properties of an Ointment (AlpaWash) Containing Brazilian Micronized Propolis and Peucedanum ostruthium Leaf Extract in Skin Ulcer in Rats Author(s): Nani Marcel, Leone Andréia, Bom Vinícius Pedro, Buszinski Andrei Felipe, Oliveira de Souza Rebeca, Pinheiro Vanessa Alves, Danapoulos Panagiota, Swikidisa Rosita, Marquele-Oliveira Franciane, Cipriani Frade Marco Andrey, Berretta Andresa Aparecida, Nogueira Rodrigo José Lupatini
Mar/Apr 2018 Pg. 172-175	Topical Ketamine in the Treatment of Complex Regional Pain Syndrome Author(s): Durham Melissa J, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H
Jan/Feb 2018 Pg. 41-46	Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy Author(s): Kosinski Tracy M, Brown Michael C, Zavala Pedro J
Jan/Feb 2018 Pg. 48	Calculations Author(s): Stockton Shelly J
Jan/Feb 2018 Pg. 57	Sodium Citrate 9% Nasal Spray for Olfactory Disorders Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 446-452	Feline Transdermal Formulation Considerations Author(s): Forsythe Lauren Eichstadt
Nov/Dec 2017 Pg. 454-461	Orodispersible Films for Compounding Pharmacies Author(s): Ferreira Anderson O, Brandão Marcos Antônio F, Raposo Francisco José, Polonini Hudson C, Raposo Nádia Rezende Barbosa
Nov/Dec 2017 Pg. 471-479	Basics of Compounding: Hot Melt Extrusion Author(s): DePasquale Seth
Nov/Dec 2017 Pg. 490	Amitriptyline 20 mg/mL in OraPlus:OraSweet Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 500-512	To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Author(s): Chuong Monica C, Taglieri Catherine A, Kerr Stephen G
Nov/Dec 2017 Pg. 513-517	Validation of the Technological Process of the Preparation "Milk by Vidal" Author(s): Savchenko LP, Mishchenko VA, Georgiyants VA
Sep/Oct 2017 Pg. 388-392	Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 408	Acetylcysteine Solutions for Inhalation Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 416	Tacrolimus 0.3-mg/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 417	Vancomycin 50 mg/mL in Oral Syrup Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 418-425	Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3) Author(s): Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Jul/Aug 2017 Pg. 282-289	Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas Author(s): Choo Winnie
Jul/Aug 2017 Pg. 293-298	Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 301-308	Basics of Sterile Compounding: Excipients Used in Injections Author(s): Akers Michael J
Jul/Aug 2017 Pg. 312	Betamethasone 0.1% and Neomycin 0.6% Gel-Cream Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 313	Castor Oil 50% in Modified Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 314	Copper Sulfate, Magnesium Sulfate, Phenylephrine, and Guaifenesin Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 316	Ferrous Sulfate 30-mg Fe/mL Oral Drops Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 319	Tacrolimus 0.06% Ophthalmic Drops Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 321	Tranilast 8% Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 347-351	Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia Author(s): Robert Julien, Sorrieul Jérémy, Rossignol Elsa, Beaussart Hélène, Kieffer Hélène, Folliard Caroline, Dupoiron Denis, Devys Catherine
May/Jun 2017 Pg. 205-211	Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report Author(s): Jones Nat, Carvalho Maria, Branvold-Herr Andrea
May/Jun 2017 Pg. 215-220	Basics of Compounding: 3D Printing--Pharmacy Applications, Part 2 Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 242-246	Absorption of Transdermal Fluoxetine Compounded in a Lipoderm Base Compared to Oral Fluoxetine in Client-owned Cats Author(s): Eichstadt Lauren R, Corriveau Lorraine A, Moore George E, Knipp Gregory T, Cooper Bruce R, Gwin Wilson E
Mar/Apr 2017 Pg. 105-108	Restructuring the Art of Health by Pharmacists: Formulation Designs with Oral Vehicles--Teaching Pharmacy Students Author(s): Benischek Rita
Mar/Apr 2017 Pg. 127-130	Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1 Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 133-142	Accuracy Considerations in Sterile Compounding Author(s): Akers Michael J
Mar/Apr 2017 Pg. 144	Calculations Author(s): Stockton Shelly J
Mar/Apr 2017 Pg. 154-159	Stability of Two Antifungal Agents, Fluconazole and Miconazole, Compounded in HUMCO RECURA Topical Cream to Determine Beyond-Use Date Author(s): Gautam Pradeep, Light Bob, Purvis Troy
Mar/Apr 2017 Pg. 164-170	Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs Author(s): Gorman Gregory, Sokom Simara, Coward Lori, Arnold John J
Mar/Apr 2017 Pg. 171-175	Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules Author(s): Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid, Polonini Hudson
Jan/Feb 2017 Pg. 22-27	Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications Author(s): Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
Jan/Feb 2017 Pg. 31-37	Analytic Methods Used in Quality Control in a Compounding Pharmacy Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 47-56	Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms Author(s): Akers Michael J
Jan/Feb 2017 Pg. 63	Nifedipine 0.5% Rectal Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 83-87	A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding Author(s): Rush Steven D, Vernak Charlene, Zhao Fang
Nov/Dec 2016 Pg. 461-467	Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy Author(s): Karara Adel H, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey
Nov/Dec 2016 Pg. 485-493	Basics of Compounding: Clinical Pharmaceutics, Part 2 Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 495-500	Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 502	Calculations Author(s): Stockton Shelly J
Nov/Dec 2016 Pg. 507	Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 517-520	Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial Author(s): Rabi Joseph, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle
Nov/Dec 2016 Pg. 521-525	Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature Author(s): Larson Bayli, Bushman Lane R, Casciano Matthew L, Oldland Alan R, Kiser Jennifer J, Kiser Tyree H
Sep/Oct 2016 Pg. 389-396	Basics of Compounding: Clinical Pharmaceutics, Part 1 Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 407	Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 410	Naproxen 5% Cream Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 411	Permethrin 1% Lotion Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 412	Progesterone 10% Cream Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 414	Tetracaine Hydrochloride 2% Topical Solution Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 438-439	A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution Author(s): Tannous Elias, Tal Yana, Amarny Kamal
Jul/Aug 2016 Pg. 271-274	Compounding Transdermal Medication for Feline Patients Author(s): Eichstadt Lauren R
Jul/Aug 2016 Pg. 298-305	Basics of Compounding: Compounding Films Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 316-317	Calculations Author(s): Stockton Shelly J
Jul/Aug 2016 Pg. 319	Gatifloxacin 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 321	Neomycin Sulfate 25-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 322	Nystatin 100,000-units Vaginal Inserts Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 323	1,2-Octanediol 5% Topical Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 324	Phytonadione 1-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 325	Plasmingen and Hyaluronate Sodium Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 326	Scopolamine Hydrobromide 0.25% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 347-350	Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product Author(s): Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
May/Jun 2016 Pg. 209-214	Basics of Compounding: Special Capsules Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 228	Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 229	Dexpanthenol 5% Nasal Spray Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 230	Indomethacin Gel Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 231	Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 232	Montelukast Sodium 5-mg Fast-Dissolving Film Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 233	Pain-Away II Headache Capsules Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 239-246	Topical Metered-dosing Dispenser Performance Evaluation Author(s): Liu Qiang, Kupiec Thomas C, Vu Nicole T
May/Jun 2016 Pg. 250-256	Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives Author(s): Trimble John, Light Bob
Mar/Apr 2016 Pg. 107-113	Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Author(s): Rabi Joseph
Mar/Apr 2016 Pg. 125-134	Basics of Compounding: Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 137-141	Formulation and Stability of Solutions Author(s): Akers Michael J
Mar/Apr 2016 Pg. 142	Calculations Author(s): Stockton Shelly J
Mar/Apr 2016 Pg. 144	Blue Goo Anti-Itch Gel Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 145	Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 146	Medicated Polyox Bandage for Skin Ulcers Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 155-158	Utilization of Compounded Medications in an Oral Medicine Practice Author(s): Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
Mar/Apr 2016 Pg. 159-163	Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups Author(s): Kirk Loren, Lewis Paul, Luu Yao, Brown Stacy
Mar/Apr 2016 Pg. 164-166	Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures Author(s): Nahata Milap C
Jan/Feb 2016 Pg. 6-10	Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis Author(s): Choo Winnie
Jan/Feb 2016 Pg. 20-27	Basic Principles of Lyophilization, Part 2 Author(s): Akers Michael J
Jan/Feb 2016 Pg. 41-45	Formulation and Stability of Solutions Author(s): Akers Michael J
Jan/Feb 2016 Pg. 48	Aprepitant 80-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 49	Aripiprazole 10-mg Oral Dissolving Tablets Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 50	Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 51	Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 52	Mupirocin Calcium 2% Cream Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 53	Resveratrol, Tocopherol Acetate, and Niacinamide Topical Gel-Cream Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 54	Thrombin 1,000 Units/mL Topical Solution, Sterile Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 55	Tropicamide 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 71-80	A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis Author(s): Turner Rob, Weaver Sean, Caserta Francesco, Brown Marc B
Nov/Dec 2015 Pg. 479-484	Mixing in a Compounding Pharmacy in the 21st Century Author(s): Standridge Rob
Nov/Dec 2015 Pg. 508	Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 512	Mupirocin 2% Nasal Ointment Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 357-365	Novel Approaches to Topical Psoriasis Therapy Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Sep/Oct 2015 Pg. 404	Aminocaproic Acid 250-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 405	Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 406	Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 407	Nimodipine 3-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 408	Ofloxacin 0.3% Otic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 409	Povidone Iodine 10% Cold Sore Paint Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 410	Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 411	Vehicle for Oral Solution (National Formulary 26) Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 412	Vehicle for Oral Solution, Sugar Free (National Formulary 26) Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 413	Vehicle for Oral Suspension (National Formulary 26) Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 414-419	Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules Author(s): Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa
Sep/Oct 2015 Pg. 428-431	Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures Author(s): Nahata Milap C
Jul/Aug 2015 Pg. 325	Balsam Peru, Castor Oil, and Trypsin Ointment Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 332	Proparacaine Hydrochloride 0.5% Ophthalmic Solution Author(s): Allen Loyd V
May/Jun 2015 Pg. 195-203	Compounded Testosterone Troches to optimize Health and the Testosterone Controversy Author(s): Guth Michael AS
May/Jun 2015 Pg. 223-230	Basics of Compounding: Compounding with Silicones Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 243	Lidocaine Hydrochloride 2% Viscous Oral Topical Solution Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 244	Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 248-251	Stability of Metronidazole Suspensions Author(s): Donnelly Ronald F, Ying James
May/Jun 2015 Pg. 252-260	Protocol of Blood Serum Eye Drops Author(s): Katsakoulas Ioannis, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos
Mar/Apr 2015 Pg. 145	Heparin 335-United/Gram Gel-Cream Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 148	Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 152-160	Transdermal Delivery of Nisoldipine: Refinement of Vehicles Author(s): El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A
Mar/Apr 2015 Pg. 161-166	Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations Author(s): Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott
Mar/Apr 2015 Pg. 167-173	Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time Author(s): Heustess Allie, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott
Jan/Feb 2015 Pg. 6-12	Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Jan/Feb 2015 Pg. 67	Lidocaine Hydrochloride 4% Topical Solution Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 68	Mupirocin 2% Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 70-72	Stability Assessment of Repackaged Bevacizumab for Intravitreal Administration Author(s): Pereboom Marieke, Becker Matthijs L, Amenchar Mostapha, Verweij Sjoerd L, van der Hoeven Ruud TM, Mulder Inge J
Jan/Feb 2015 Pg. 78-85	Stability of Suspensions: Theoretical and Practical Considerations before Compounding Author(s): Hadziabdic Jasmina, Elezovic Alisa, Rahic Ognjenka, Mujezin Indira, Vranic Edina
Nov/Dec 2014 Pg. 462-468	Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Medications in a Rural Setting: A Case Study from the Delmarva Peninsula Author(s): Sherr Zachary, Karara Adel H
Nov/Dec 2014 Pg. 479-484	Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms Author(s): Akers Michael J
Nov/Dec 2014 Pg. 492-493	Calculations Author(s): Stockton Shelly J
Nov/Dec 2014 Pg. 504-511	Skin Penetration and Antinociception of Topical Gabapentin Formulations Author(s): Bryson Evan, Asbill Scott, Sweitzer Sarah
Nov/Dec 2014 Pg. 512-515	In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations Author(s): Heustess Allie, Asbill Scott, Eagerton David, Arnold John
Nov/Dec 2014 Pg. 516-519	Effect of Emulsifier Pairs on Physical Stability of Emulsions Containing Three Different Natural Oils Author(s): Boonme Prapaporn, Maneenuan Duangkhae
Nov/Dec 2014 Pg. 520-525	High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Author(s): Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy
Sep/Oct 2014 Pg. 356	PreScription: What is a Compounding Pharmacist? Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 366-369	To Compound or Not to Compound: A Veterinary Transdermal Discussion Author(s): Eichstadt Lauren R, Davidson Gigi S
Sep/Oct 2014 Pg. 370-377	Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report Author(s): Mixon Bill, Mixon Jan, Isbey Edward K III, Sprinkle Shari
Sep/Oct 2014 Pg. 409	Bacitracin Topical Ointment Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 415	Sulfamethoxazole and Trimethoprim Oral Solution Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 278-286	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014 Pg. 287-290	Oral Mucosal Immunotherapy Using a Toothpaste Delivery System for the Treatment of Allergic Rhinitis Author(s): Reisacher William, Rudner Shara, Kotik Viktoriya
Jul/Aug 2014 Pg. 305-310	Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2 Author(s): Vu Nicole, Lou Jessica R, Kupiec Thomas C
Jul/Aug 2014 Pg. 313-317	Basics of Compounding Sterile Preparations: Nomenclature and Considerations Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 318-319	Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 332-340	Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream Author(s): Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
Jul/Aug 2014 Pg. 341-344	Assessing the Use of Food Coloring as an Appropriate Visual Guide for Homogenously Mixed Capsule Powders in Extemporaneous Compounding Author(s): Hoffmann Brittany, Carlson Christie, Rao Deepa A
Jul/Aug 2014 Pg. 345-347	Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita
Jul/Aug 2014 Pg. 348-350	Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita, Addo Richard T
May/Jun 2014 Pg. 182-188	A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications Author(s): Warner Meredith, Tuder Dmitry
May/Jun 2014 Pg. 190-200	Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice Author(s): McNulty John P, Muller George
May/Jun 2014 Pg. 213-221	Quality Control Analytical Methods: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 1 Author(s): Vu Nicole, Lou Jessica R, Kupiec Thomas
May/Jun 2014 Pg. 228-230	Basics of Compounding: Tips and Hints, Part 3: Compounding with Ointments, Creams, Pastes, Gels, and Gel-creams Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 235	Butorphanol Tartrate 10-mg/mL Nasal Spray Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 236	Dibucaine 1% Ointment Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 248-252	Investigation of Physical and Chemical Stability of an Ointment with Herbals Author(s): Zdoryk Oleksandr A, Khokhlova Kateryna O, Georgiyants Victoriya A, Vyshnevska Liliia I
May/Jun 2014 Pg. 256-261	Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery Author(s): Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
Mar/Apr 2014 Pg. 123-130	Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding Author(s): Vu Nicole, Nguyen Devin, Kupiec Thomas C
Mar/Apr 2014 Pg. 137-138	Basics of Compounding: Tips and Hints, Part 2: Compounding with Solutions, Suspensions, Emulsions, and Lotions Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 14-19	Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report Author(s): Zur Eyal
Jan/Feb 2014 Pg. 42-45	Tips and Hints: Powders, Capsules, Tablets, Suppositories, and Sticks Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 70-77	The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study Author(s): Ruiz Andres D, Daniels Kelly R
Nov/Dec 2013 Pg. 490-495	Basics of Compounding: Basics of Compounding with Balsams Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 512-514	Comparing Suppository Mold Variability Which Can Lead to Dosage Errors for Suppositories Prepared with the Same or Different Molds Author(s): Alexander Kenneth S, Baki Gabriella, Hart Christine, Hejduk Courtney, Chillas Stephanie
Nov/Dec 2013 Pg. 520-525	Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream Author(s): Wang Xuexuan, Black Laura
Sep/Oct 2013 Pg. 364-368	Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms Author(s): McElhiney Linda F
Sep/Oct 2013 Pg. 370-374	Chemical Penetration Enhancers Author(s): Newton Stephen J
Sep/Oct 2013 Pg. 380-383	Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease Author(s): McElhiney Linda F
Sep/Oct 2013 Pg. 384-387	Methocarbamol Suspension for the Treatment of Rhabdomyolysis in Equines Author(s): Pruitt Bobby N III
Sep/Oct 2013 Pg. 412	Calculations Author(s): Stockton Shelly J, Saluja Hardeep Singh
Sep/Oct 2013 Pg. 424-431	In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs Author(s): Pinheiro Vanessa A, Danopoulos Panagiota, Demirdjian Lara, Nogueira Rodrigo J L, Dubois Fanny
Jul/Aug 2013 Pg. 312-322	Basics of Compounding: Foam Dosage Forms Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 347-350	Physical Stability of Coconut Oil Lotions Formulated Using a Hydrophile-lipophile System of Various Emulsifier Pairs Author(s): Boonme Prapaporn, Maneenuan Duangkhae, Channarong Sunee
May/Jun 2013 Pg. 201-204	Optimizing Third-party Reimbursement for Compounded Medications Author(s): McElhiney Linda F
May/Jun 2013 Pg. 247-253	Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Author(s): Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
May/Jun 2013 Pg. 254-261	Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline Author(s): Klemmer Anja, Krämer Irene, Kamin Wolfgang
Mar/Apr 2013 Pg. 113-123	Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities Author(s): Zur Eyal
Mar/Apr 2013 Pg. 165-167	Stability of Minoxidil in Espumil Foam Base Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul A
Jan/Feb 2013 Pg. 10-22	Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients Author(s): Zur Eyal
Jan/Feb 2013 Pg. 28-38	Treatment Options for Male Hypogonadism Author(s): Biundo Bruce
Nov/Dec 2012 Pg. 462-469	Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents Author(s): Zur Eyal
Nov/Dec 2012 Pg. 480-483	Colds and Cough Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 510-512	Stability of Ursodiol in SyrSpend SF Cherry Flavored Author(s): Geiger Christine M, Voudrie Mark A II, Sorenson Bridget
Nov/Dec 2012 Pg. 516-523	Rice Bran Oil: Preparation and Evaluation of Novel Liquisolid and Semisolid Formulations Author(s): Ammar Hussein O, Al-Okbi Sahar Y, Mostafa Dina M, Helal Amr M
Sep/Oct 2012 Pg. 386-393	Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies Author(s): Zur Eyal
Sep/Oct 2012 Pg. 416	Calculations Author(s): Stockton Shelly J
Sep/Oct 2012 Pg. 428-430	Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date Author(s): Peacock Gina F, Sauvageot Jurgita
Sep/Oct 2012 Pg. 434-437	Compounding of Slow-release Niacinamide Capsules: Feasibility and Characterization Author(s): Radojkovic Branko, Milic Jela, Calija Bojan
Jul/Aug 2012 Pg. 270-274	A Concise Discussion of Headache Types, Part 3: Migraine Author(s): Williams LaVonn A, Allen Loyd V Jr
May/Jun 2012 Pg. 196-205	Burning Mouth Syndrome: A Discussion of a Complex Pathology Author(s): Zur Eyal
May/Jun 2012 Pg. 210-218	Treatment and Prevention of Insect Bites: Mosquitoes Author(s): Williams LaVonn A, Allen Loyd V Jr
May/Jun 2012 Pg. 248-252	In Vitro Percutaneous Absorption of Ketoprofen and Testosterone: Comparison of Pluronic Lecithin Organogel vs. Pentravan Cream Author(s): Lehman Paul A, Raney Sam G
Mar/Apr 2012 Pg. 110-114	Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy Author(s): Griffee Chris, Delano Amy
Jan/Feb 2012 Pg. 80-81	Chemical Stability of Pentoxifylline in a Topical Cream Author(s): Gupta Vishnu D
Jan/Feb 2012 Pg. 17-21	Vitamins: Therapy or Hype Author(s): Wynn Tom, Hoffrogge Zach
Jan/Feb 2012 Pg. 62-63	The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs Author(s): Bramwell Bethany L, Williams LaVonn A
Nov/Dec 2011 Pg. 450-457	Compounding for Treatment of Equine Infectious Diseases: An Overview Author(s): Bramwell Bethany L
Nov/Dec 2011 Pg. 458-463	Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Author(s): Zur Eyal
Nov/Dec 2011 Pg. 464-469	Diaper Rash Relief: Common Sense Remedies and Treatments Author(s): Wiliams Kacee D, Williams LaVonn
Nov/Dec 2011 Pg. 498	Calculations Author(s): Stockton Shelly J
Nov/Dec 2011 Pg. 500	Cefepime 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 501	Citric Acid 3% Mouthrinse Solution Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 502	Dapsone 5% Topical Gel Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 503	Lavender Oil 4% in Polyethylene Glycol Ointment Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 507	Tobramycin Fortified 13.5-mg/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 508	Vancomycin 31-mg/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 509	Vancomycin 2% in Silver Sulfadiazine Cream Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 510-514	A New Proposal: Calculating Density Factors for Drugs Using Cocoa Butter as the Standard Author(s): Walker Heather, Sridhar Vishak, Alexander Kenneth S
Nov/Dec 2011 Pg. 521-525	Development and Statistical Analysis of Glipzide-Loaded Fast-Dissolving Tablets Using Plantago ovata Husk as a Superdisintegrant Author(s): Jha Antesh Kr, Chetia D
Sep/Oct 2011 Pg. 376-380	Magic Mouthwashes: A Literature Review and Discussion of Common Compositions Author(s): McElhiney Linda F
Sep/Oct 2011 Pg. 386-387	Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient Author(s): McElhiney Linda F
Sep/Oct 2011 Pg. 418	Carvedilol 0.625-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 419	Granisetron Hydrochloride 0.2-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 420	Lorazepam 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 421	Metoprolol Tartrate 1.25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 422	Nifedipine 1-mg/500-mg Oral Powder Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 423	Nifedipine 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 424	Rebamipide Rectal Enema Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 425	Sotalol 5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 426	Sulfadiazine 100-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 427	Ursodiol 50-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 308-315	Transdermals: The Skin as Part of a Drug Delivery System Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 339	Magnesium Sulfate Paste Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 302-307	Treating Inner Ear Disorders with Intratympanic Drug Administration Author(s): McElhiney Linda F
May/Jun 2011 Pg. 194-199	Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient Author(s): McElhiney Linda F
May/Jun 2011 Pg. 200-203	Extemporaneous Preparation of Sertraline Cream for Transdermal Administration Author(s): Wynn Tom, Goetsch Daniel
May/Jun 2011 Pg. 204-213	Treatment Options for Psoriasis Author(s): Williams LaVonn A, Humphreys Erica
May/Jun 2011 Pg. 242	Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 243	Diclofenac Sodium 1% Topical Gel Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 244	Ibuprofen 5% Topical Cream Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 247	Sport Body Cooler Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 248	Tannic Acid 5% Alcohol Gel Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 249	Triamcinolone 0.1% Lotion Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 245	Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 250	Triclosan 2% Topical Cream Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 251	Wound Cleaner Solution Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 102-112	Testosterone Levels in an Aging Population: Screen, Measure, and Restore Author(s): Kells John, DollbaumCharles M
Mar/Apr 2011 Pg. 162	Mandl's Paint Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 164	Oral Film Strip Vehicle Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 165	Tea Tree Oil Acne Gel Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 166-169	Nifedpine in Compounded Oral and Topical Preparations Author(s): McCluskey Susan V, Brunn Gregory J
Mar/Apr 2011 Pg. 174-175	PostScription: Commentary: Discussion on the Safety of Topical Prilocaine Author(s): Bramwell Bethany L
Jan/Feb 2011 Pg. 13-18	Current Concepts in the Treatment of Recurrent Aphthous Ulcers Author(s): Bramwell Bethany L, Williams LaVonn A
Jan/Feb 2011 Pg. 27-31	Goliath: Case Report on a Canine Case of Epilepsy Author(s): Ameijeiras Carlos, Ray Jody, Jordan Dinah G, Garcia Abby Furr
Jan/Feb 2011 Pg. 41	Toxicities Associated with Topical Anesthetics Author(s): Bramwell Bethany L
Jan/Feb 2011 Pg. 64	Diclofenac Sodium 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 65	Hydrocortisone Acetate 1% Gel, Alcohol-Free Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 66	Ibuprofen 5% Gel Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 67	Mandelic Acid 5% Cream Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 68	Methotrexate 30-mg/g Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 69	Piroxicam 1% Gel Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 70	Pramoxine 1% Cream Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 71	Sodium Nitroprusside and Sodium Thiosulfate Intravenous Admixture Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 72	Terbenafine Hydrochloride Bilayer Nail Lacquer Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 73	Vancomycin Hydrochloride 25-mg/mL Solution Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 74-77	Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs Author(s): Elder Deborah Lester, Zheng Bo, White Catherine A, Li Dawei
Nov/Dec 2010 Pg. 484-486	All-Purpose Nipple Ointment: A Compounding Solution to Common Problems with Breastfeeding Author(s): Williams KaCee D
Nov/Dec 2010 Pg. 488-491	Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin Author(s): Rudner Shara, Browne Paul
Nov/Dec 2010 Pg. 512	Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 513	Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 514	Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 517	Capsaicin 0.05% Clear Medication Stick Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 518	Glutathione 25% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 519	Gramicidin 13% Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 521	Ketoprofen 2% Oral Gel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 472-478	Extemporaneous Compounding of Medicated Ointment Author(s): Nagel Karen, Ali Fatima, Al-Khudari Sarah, Khan Ayesha, Patel Khushbu, Patel Nikunj, Desai Archana
Nov/Dec 2010 Pg. 480-483	"My Hip Hurts": A Collaboration of Clinicians in the Treatment of Adhesive Capsulitis to Optimize Patient Care Author(s): Cox Chris
Nov/Dec 2010 Pg. 520	Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 522-525	Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date Author(s): Pignato Alyssa, Pankaskie Marvin, Birnie Christine
Sep/Oct 2010 Pg. 374-380	Bioidentical Hormones in the News Author(s): Bramwell Bethany L
Sep/Oct 2010 Pg. 395-399	Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients Author(s): Muller George, Case Tyler, Deen Griffin L
Sep/Oct 2010 Pg. 420	Alpha-Bisabolol Mouthwash Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 422	Icy Blue Camphorated Gel Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 423	Carvedilol 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 424	Buspirone 2.5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 421	Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 425	Triclosan 0.28% Mouthwash Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 426	Rufinamide 40-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 427	Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 428	Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 429	Polidocanol 0.5% Wound Spray Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 270-274	Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together Author(s): McElhiney Linda F
Jul/Aug 2010 Pg. 276-282	Recommendations for Compounding Medications for Feeding Tube Administration Author(s): Klang Mark
Jul/Aug 2010 Pg. 301-304	Considerations for Percutaneous Absorption Author(s): Newton Stephen J, Cook Jennifer M
Jul/Aug 2010 Pg. 334	Amitriptyline Hydrochloride Suppositories Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 310-314	Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Author(s): Christiansen Joel, White Lyndell
Jul/Aug 2010 Pg. 322-326	Basics of Compounding: Basics of Compounding with Organic Salts Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 335	Ampicillin 250-mg Suppository Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 336	Antazoline Phosphate and Xylometazoline Hydrochloride Ophthalmic Drops Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 341	Flurbiprofen 5% Bioadhesive Gel for Gingivitis Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 342-345	Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping Author(s): Tong Henry H Y, Chan Hokman, Du Zhen, Zheng Ying
May/Jun 2010 Pg. 182-192	Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010 Pg. 200-203	Topical Medications for Orofacial Neuropathic Pain Author(s): Bramwell Bethany L
May/Jun 2010 Pg. 204-206	Managing Pain with Transdermal Ketoprofen Author(s): Williams KaCee D
May/Jun 2010 Pg. 210-213	Potential Treatments for Radiation Dermatitis Author(s): Corsini Lindsay
May/Jun 2010 Pg. 230	Calculations Author(s): Stockton Shelly J
May/Jun 2010 Pg. 240	Bacitracin 10,000-Units/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 241	Carprofen 2.5-mg/mL Oral Suspension, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 242	Celecoxib 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 243	Clozapine 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 244	Cohen's Rectal Ointment Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 245	Cyclophosphamide 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 246	Lansoprazole 3-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 247	Rifaximin 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 248	Sunitinib 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 249	Voriconazole 40-mg/mL Oral Suspension, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 250-256	Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration Author(s): de Villiers Melgardt M, Vogel Laura, Bogenschutz Monica C, Fingerhut Bonnie J, D'Silva Joseph B, Moore Anne
Mar/Apr 2010 Pg. 112-115	Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient Author(s): McElhiney Linda F
Mar/Apr 2010 Pg. 150	Acyclovir 5% in Oral Adhesive Paste Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 151	Acyclovir 200-mg/5-mL Oral Suspension (From the Injection) Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 152	Ciclopirox 10% in Isopropyl Alcohol Nail Solution Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 153	Clotrimazole 1% Oral Adhesive Paste Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 154	Cyclosporin 10-mg/g in Oral Adhesive Paste Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 155	Dexpanthenol 5% Gel-Cream Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 158	Plasticized Hydrocarbon Gel Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 159	Oral Adhesive Paste Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 21-25	Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet Author(s): McElhiney Linda F, Cheng Angela, Meshberger Laura, Imai Lara
Jan/Feb 2010 Pg. 40-45	Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Author(s): Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R
Jan/Feb 2010 Pg. 68	Ketoprofen 100-mg/5-mL Mouth Rinse Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 69	Metronidazole in Normal Saline Enema Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 70	Ophthalmic Toning-Lubricating Drops Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 72	Testosterone 1% in Alcoholic Gel Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 73	Tetracaine 4% and Menthol 5% Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 75	Trigger Point Gel Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 6-8	When Traditional Medicine Fails Author(s): Bash Robert
Jan/Feb 2010 Pg. 74	Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2009 Pg. 554	Cidofovir 0.2-mg/mL Intravitreous Injection Author(s): Allen Loyd V Jr
Nov/Dec 2009 Pg. 555	Fluconazole 2% Topical Microemulsion Author(s): Allen Loyd V Jr
Nov/Dec 2009 Pg. 540-543	Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops Author(s): Reed-Kane Dana, Carlson Rachel A, Kupiec Thomas C, Vu Nicole
Nov/Dec 2009 Pg. 557	Ichthammol 10% Otic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2009 Pg. 569-571	The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel Author(s): Arnold John J, Asbill Scott
Nov/Dec 2009 Pg. 558	Lubow's Solution Author(s): Allen Loyd V Jr
Nov/Dec 2009 Pg. 559	Miconazole 1% Ophthalmic Solution, Veterinary Author(s): Allen Loyd V Jr
Nov/Dec 2009 Pg. 560	Topiramate 6-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2009 Pg. 561	Twevan Cream Author(s): Allen Loyd V Jr
Nov/Dec 2009 Pg. 562	Voriconazole 2% Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2009 Pg. 564-568	Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes Author(s): Bailey Caroline, Aloumanis Vasileios, Walker Brian, Ben Michel, McGuire Jason, Vu Nicole
Nov/Dec 2009 Pg. 572-573	Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions Author(s): Parish Roy C
Sep/Oct 2009 Pg. 358-360	Transdermal Dosing Considerations for Veterinarians Author(s): Williams KaCee D
Sep/Oct 2009 Pg. 367-371	Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret Author(s): Williams LaVonn A, Riley Kari
Sep/Oct 2009 Pg. 390-391	Recommended Tips for Treating Veterinary Patients Author(s): Bramwell Bethany L, Williams LaVonn A
Sep/Oct 2009 Pg. 428	Aceclofenac 1.5% Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Sep/Oct 2009 Pg. 432	Ferric Pyrophosphate 50-mg/mL Solution for Iontophoresis Author(s): Allen Loyd V Jr
Sep/Oct 2009 Pg. 433	Lidocaine 10% Oral Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Sep/Oct 2009 Pg. 434	Mechlorethamine Hydrochloride 0.02% Topical Author(s): Allen Loyd V Jr
Sep/Oct 2009 Pg. 435	Myristyl Nicotinate 5% Topical Gel Author(s): Allen Loyd V Jr
Sep/Oct 2009 Pg. 436	Nitroglycerin 4-mg Suppository Author(s): Allen Loyd V Jr
Sep/Oct 2009 Pg. 438-439	Chemical Stability of Scopolamine Hydrobromide Nasal Solution Author(s): Gupta Vishnu D
Jul/Aug 2009 Pg. 314-317	Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding Author(s): Glaser Rebecca L, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel
Jul/Aug 2009 Pg. 337	Moxifloxacin 20-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 338	Mupirocin 1% (20-mg) Vaginal Suppository Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 340	Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 342-344	Quality of Progesterone Suppositories Prepared by FIRST-Progesterone VGS 50 Kit or Traditional Compounding Method: In Vitro Comparison Author(s): Chauhan Harsh, Atef Eman
Jul/Aug 2009 Pg. 345-349	Women's Perspective on Progesterone: A Qualitative Study Conducted in Australia Author(s): Spark M Joy, Dunn Rebecca A, Houlahan Kelli L
Jul/Aug 2009 Pg. 270-275	The Physiologic Role and Use of Estriol Author(s): Paoletti Jim E
Jul/Aug 2009 Pg. 276-279	Hormone Treatment Options for Males: What to Do for Men with Low Testosterone Author(s): Biundo Bruce
Jul/Aug 2009 Pg. 332	Alcohol-based Carbomer Gel Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 333	Benzoyl Peroxide 10% Gel Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 334	Clindamycin 100-mg Vaginal Suppositories Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 335	Dexamethasone and Furosemide Injection Author(s): Allen Loyd V Jr
May/Jun 2009 Pg. 259-261	Formulation Optimization Study for an Immediate-Release Tablet Author(s): Kyriacos Soula, Dimassi Hani
May/Jun 2009 Pg. 182-190	Update on Managing Neuropathic Pain Author(s): McNulty Jack P, Muller George
May/Jun 2009 Pg. 192-195	Elegant Compounded Solutions for the Treatment of Thrombosed External Hemorrhoids Author(s): Zur Eyal
May/Jun 2009 Pg. 196-213	Missives from Iraq: Compounding the Theatre of War--Phenytoin Solution Heals Severe Refractory Wounds: An Anecdotal Report Author(s): Muller George, Hall Linda A, Stovall Audrey, Peters Susan H, Vail Jane
May/Jun 2009 Pg. 214-217	Case Report: Lidocaine Mucoadhesive Buccal Tablets for Local Relief of Mouth Ulcers Author(s): Young Jennifer L, Bogner Robin H
May/Jun 2009 Pg. 218-219	Safe Use of Topical Local Anesthetic Medications for Pain Management Author(s): Epshteyn Mikhail G, Pepin Steven M
May/Jun 2009 Pg. 220-221	Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report Author(s): Muller George
May/Jun 2009 Pg. 240	Analgesic Compound Lotion, Clear Author(s): Allen Loyd V Jr
May/Jun 2009 Pg. 241	Hydromorphone Hydrochloride 10-mg/mL Oral Drops Author(s): Allen Loyd V Jr
May/Jun 2009 Pg. 250-253	Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A Comparison of Two Methods of Compounding Author(s): Garg Sanjay, Svirskis Darren, Al-Kabban Majid, Farhan Samer, Komeshi Mohammed, Lee Jacky, Liu Quincy, Naidoo Sacha, Kairuz Therese
May/Jun 2009 Pg. 254-258	Stability of Pergolide Mesylate Oral Liquid at Room Temperature Author(s): Shank Brandon R, Ofner Clyde M III
May/Jun 2009 Pg. 242	Lidocaine 2% Popsicle Author(s): Allen Loyd V Jr
May/Jun 2009 Pg. 243	Morphine Sulfate 10-mg/mL Oral Solution Author(s): Allen Loyd V Jr
May/Jun 2009 Pg. 244	Morphine Sulfate 50 mg/mL in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
May/Jun 2009 Pg. 245	Oxycodone Hydrochloride 10 mg/mL in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
May/Jun 2009 Pg. 246	Oxycodone Hydrochloride 10-mg and Dextromethorphan 20-mg capsules Author(s): Allen Loyd V Jr
May/Jun 2009 Pg. 247	Oxycodone Hydrochloride 20-mg Suppository Author(s): Allen Loyd V Jr
May/Jun 2009 Pg. 248	Promethazine 20-mg and Acetaminophen 325-mg Suppositories Author(s): Allen Loyd V Jr
May/Jun 2009 Pg. 249	Propoxyphene Hydrochloride 100-mg with Dextromethorphan Hydrobromide 30-mg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2009 Pg. 170-174	Stability of Melatonin in an Extemporaneously Compounded Sublingual Solution and Hard Gelatin Capsule Author(s): Haywood Alison, Burrell Anthony, van Bred Karin, George Rani, Testa Chris, Norris Ross
Mar/Apr 2009 Pg. 153	Aprepitant 20-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2009 Pg. 154	Chloroquine Phosphate 64.5-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2009 Pg. 155	Doxorubicin Hydrochloride 1-mg/mL in Sodium Chloride Solution Intravesical Instillation Author(s): Allen Loyd V Jr
Mar/Apr 2009 Pg. 156	Ionic Hydration Solution for Anti-Cancer Therapy Author(s): Allen Loyd V Jr
Mar/Apr 2009 Pg. 157	Metronidazole 2.1-mg/mL in 5.25% Dextrose Injection Author(s): Allen Loyd V Jr
Mar/Apr 2009 Pg. 158	Nicotine Rectal Enema Author(s): Allen Loyd V Jr
Mar/Apr 2009 Pg. 159	Thiothixene Hydrochloride 2-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2009 Pg. 160	Tolterodine 2-mg/5-mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2009 Pg. 161	Vasopressin Tannate 5 Pressor Units Per mL in Oil Injection Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 6-12	Compounding for Pediatric Patients: Case Reports and Formulations Author(s): Mixon William, Angelle Patricea, Yoch Douglas
Jan/Feb 2009 Pg. 14-18	Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports Author(s): Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
Jan/Feb 2009 Pg. 25-29	Compounding with Sucralfate for the Treatment of External Wounds Author(s): Wynn Tom, Williams LaVonn A
Jan/Feb 2009 Pg. 32-36	Identifying the Criteria of a Valid Stability Study Author(s): Williams LaVonn A, Hastings Mitchell Blaine
Jan/Feb 2009 Pg. 64	Acetaminophen, Pseudoephedrine Hydrochloride, and Chlorpheniramine Maleate Powder Packets Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 65	Amphotericin B, Chloramphenicol Palmitate, Hydrocortisone, and Sulfanilamide Otic Powder Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 66	Dextromethorphan Hydrobromide 10% and Guaifenesin 10% Rapidly Penetrating Gel Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 67	Dextromethorphan Hydrobromide 30-mg Troches Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 68	Diaper Rash Cream with Miconazole Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 69	Diphenhydramine Hydrochloride 25-mg Gelatin Troches Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 70	Electrolyte Lollipop (Adult) Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 71	Hydrogen Peroxide 1.5% and Sodium Fluoride 0.5-mg/mL Oral Rinse Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 72	Peruvian Balsam, Zinc Stearate, Boric Acid, and Talcum Powder Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 73	Tetracaine 0.025% Popsicles Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 74-77	Testing of Estradiol in a Compounded Cream and a Stock Solution Author(s): Buderer Matthew J, Buderer Nancy M
Sep/Oct 2008 Pg. 392-397	Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases Author(s): Mixon William, Helms Scott R
Sep/Oct 2008 Pg. 446	Aceclofenac 1.5% Gel-Cream Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 447	Acetaminophen 10-mg/mL Rectal Solution Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 449	Dichlorobenzyl Alcohol Tooth Gel Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 450	Estradiol 0.1% Vaginal Solution Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 451	Flurandrenolide Topical Film Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 452	Ketoprofen 20% Topical Solution Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 453	Lidocaine Adhesive System Gel Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 454	Piroxicam 5% and Dexpanthenol 5% Gel Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 455	Propafenone 1.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 482-487	Compounding Challenges for Immunocompromised Patients Author(s): McElhiney Linda F
Nov/Dec 2008 Pg. 498-504	Case Reports: Compounding to Relieve Arthritis Pain Author(s): Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
Nov/Dec 2008 Pg. 543	Indomethacin 2% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 544	Ketorolac Tromethamine 2% Topical Gel Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 546	Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 540	Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 541	Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 549	Morphine Sulfate 20-mg and Prochlorperazine Maleate 10-mg Troches Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 364	Zirconium Oxide Lotion Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 365-367	Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada Author(s): Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
Jul/Aug 2008 Pg. 372-374	Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms Author(s): Gupta Vishnu D
Jul/Aug 2008 Pg. 295-304	Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
Jul/Aug 2008 Pg. 340-343	Quality-Control Analytical Methods: Homogeneity of Dosing Forms Author(s): Kupiec Thomas C, Vu Nicole, Branscum David
Jul/Aug 2008 Pg. 355	Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 356	Silicone Cream Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 357	Sodium Chloride 0.9% Ointment Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 358	Squalene 0.2% Cream Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 359	Sucralfate and Hyaluronic Acid Ointment Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 360	Tretinoin and (-)Alpha-Bisabolol Gel Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 361	Tretinoin and Dexpanthenol Gel Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 362	Ultrasonic Adhesive Gel Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 363	Vitamin A Suppository Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 260	African Scalp Lotion Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 261	Benzyl Benzoate Lotion Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 262	Calcium Gluconate 2.5% Topical Gel Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 263	Lubricating Gel Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 264	Meloxicam 0.3% Topical Gel Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 265	Miconazole Nitrate 2%, Deoxy-D-Glucose 0.2%, and Hydrocortisone 0.4% Lip Balm Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 266	Potassium Nitrate/Benzocaine/Tetracaine Dental Gel Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 267	Promethazine Hydrochloride 2.5-mg/mL Rectal Solution Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 268	Tolnaftate 1% Antifungal Microemulsion Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 269	Valsartan 4-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 182-190	Topical Treatment of Neuropathic Pain Author(s): Vadaurri Vince
May/Jun 2008 Pg. 192-197	Compounded Local Anesthetics to Minimize Pain from Medical Procedures Author(s): McElhiney Linda F
May/Jun 2008 Pg. 200-207	Dilution and Compounding of Ziconotide for Intrathecal Administration Author(s): Buchta Tony, Fakata Keri, Stuart William
May/Jun 2008 Pg. 270-273	Evaluation of the Percutaneous Absorption of Promethazine Hydrochloride, In Vitro, Using the Human Ex Vivo Skin Model Author(s): Bassani August S, Banov Daniel, Lehman Paul A
Mar/Apr 2008 Pg. 146	Acyclovir 5% Topical Ointment Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 163-169	Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting Author(s): de Oliveira Ferreira Anderson, Holandino Carla
Mar/Apr 2008 Pg. 147	Alum 6.5% Topical Cream Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 148	Aminacrine Hydrochloride 0.1% Cream Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 149	Butesin Picrate 1% ointment Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 150	Carbamazepine Topical Preparations Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 151	Chlorhexidine Gel Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 152	EDTA 1% Cream Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 153	Erythromycin 1% and Neomycin Sulfate Ointment Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 154	Heparin Gel-Cream Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 155	Hydrogen Peroxide 8% Cream Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 8-14	Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration Author(s): Dib Jean G, Abdulmohsin Saud
Jan/Feb 2008 Pg. 64	Cyclosporine Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 65	Diclofenac Sodium 1% Soft-Patch Gel Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 66	Diclofenac Sodium 1% Soft-Patch Lipophilic Gel Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 67	Diltiazem 5% in Lipoderm, Veterinary Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 68	Emetine Hydrochloride 30-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 69	Flosulide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 70	Pentoxifylline 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 71	Piroxicam 1% Soft-Patch Lipophilic Gel Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 72	Piroxicam 1% Soft-Patch Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 73	Trimethoprim 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2007 Pg. 504	Aloe Vera Gel Author(s): Allen Loyd V Jr
Nov/Dec 2007 Pg. 505	Breast Care Cream Author(s): Allen Loyd V Jr
Nov/Dec 2007 Pg. 506	Castor Oil and Trypsin Ointment Author(s): Allen Loyd V Jr
Nov/Dec 2007 Pg. 514-519	Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen Author(s): Zugerman Jessie Jean M, Reed Thomas C
Nov/Dec 2007 Pg. 507	Chlorhexidine 2% Gel Author(s): Allen Loyd V Jr
Nov/Dec 2007 Pg. 508	Coal Tar 2% and Allantoin 2.5% Cream Author(s): Allen Loyd V Jr
Nov/Dec 2007 Pg. 509	Foscarnet 2.5% Topical Cream Author(s): Allen Loyd V Jr
Nov/Dec 2007 Pg. 510	Interferon alfa-2b Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2007 Pg. 512	Miconazole 2% Oral Gel Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 364-374	Rabbit Medicine Author(s): Jordan Dinah G
Sep/Oct 2007 Pg. 416	Acetaminophen 500-mg and Diphenhydramine Hydrochloride 25-mg Hot Therapy Packs Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 419	Betamethasone Valerate 0.1% Topical Gel Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 420	Dexpanthenol 5% Gel-Cream Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 421	Diclofenac Sodium 75-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 423	Hydrocortisone 0.5% Ethanolic Gel Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 424	Neomycin 0.05% Topical Gel Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 433-437	Isoniazid Release from Suppositories Compounded with Selected Bases Author(s): Hudson Kristofer C, Asbill C Scott, Webster Andrew A
Jul/Aug 2007 Pg. 329	Ketoconazole 25-mg Liquid Suppository Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 330	Mebeverine Hydrochloride 20% gel Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 332	Oseltamivir 12-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 333	Phenytoin Sodium 20-mg/mL Topical Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 337	Vehicle N Formulas Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 220-225	Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
May/Jun 2007 Pg. 238-239	Calculations - Compounding for Pain Management Author(s): Stockton Shelly J
May/Jun 2007 Pg. 242	Benazepril 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 243	Cholecalciferol 40,000-IU/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 244	Folic Acid 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 245	Glycopyrrolate 0.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 246	Isoproterenol Compound Elixir Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 247	Levothyroxine Sodium 40-micro-g/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 248	Losartan Potassium 2.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 249	Methylphenidate 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 250	Thiamine Hydrochloride 100-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 251	Trovafloxacin Mesylate 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 181-184	Transdermal Gel in the Treatment of Postoperative Pain Author(s): Alexander Kayla, Wynn Tom
May/Jun 2007 Pg. 187-192	Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited Author(s): Vail Jane
May/Jun 2007 Pg. 194-199	The Rectal Rocket: A Two-Day Treatment for Hemorrhoids Author(s): Vail Jane
Mar/Apr 2007 Pg. 95-104	Insulins: Historical and Current Perspectives Author(s): Vance Dwight A
Mar/Apr 2007 Pg. 106-110	Compounding for the Complications of Diabetes: Interviews with Compounding Pharmacists George B. Muller, RPh, and Jerrod Roberts, DPh Author(s): Vail Jane
Mar/Apr 2007 Pg. 122-124	Compounded Treatments for Erectile Dysfunction: A Common Complication of Diabetes Author(s): Fields Shannon W
Mar/Apr 2007 Pg. 131	Case Report: Shingles Triple Cream in the Treatment of Herpes Zoster Author(s): Fields Shannon W
Mar/Apr 2007 Pg. 145-148	Quality Control Analytical Methods: Considerations in Compounding Peroral Solid Dosage Forms Author(s): Vu Nicole
Mar/Apr 2007 Pg. 132-135	Innovative Uses of Compounded Tranilast: An Interview with Compounding Pharmacist Larry J. Frieders, RPh Author(s): Vail Jane
Jan/Feb 2007 Pg. 5-8	Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Jan/Feb 2007 Pg. 17-19	Pediatric Oral Formulations: A Continual Challenge Author(s): Hurtado Josephine, Moffett Brady S
Jan/Feb 2007 Pg. 27	Case Report: Treatment of Labial Adhesions in a Child Author(s): Fields Shannon W
Jan/Feb 2007 Pg. 69	Caffeine Citrate 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 70	Carbidopa 1.25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 71	Clonidine Hydrochloride 0.1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 72	Dexamethasone 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 73	Fluoxetine Hydrochloride 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 74	Lansoprazole 3-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 75	Methyldopa 25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 76	Metolazone 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 79-81	Chemical Stability of Desonide in Ear Drops Author(s): Gupta Vishnu D
Nov/Dec 2006 Pg. 428-433	BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle Author(s): Benischek Rita L
Nov/Dec 2006 Pg. 434-435	Ronidazole in the Treatment of Trichomonad Infections in Cats Author(s): Davidson Gigi S
Nov/Dec 2006 Pg. 453	Chloral Hydrate 50-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 454	Cyclophosphamide 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 455	Disulfiram 25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 456	Gabapentin 100-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 457	Hydralazine Hydrochloride 1-mg/mL or 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 458	Indomethacin 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 459	Naltrexone 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 460	Terbutaline Sulfate 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 461	Valacyclovir 50-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 469-477	Validation Study of the Unguator, an Apparatus for Compounding Dermatological Preparations Author(s): Piette Marie, Stassen Thibaut, Kinget Renaat, Delattre Luc
Nov/Dec 2006 Pg. 411-414	Compounding for Feline Herpetic Keratitis Author(s): Davidson Gigi S
Nov/Dec 2006 Pg. 417-418	Compounding for Veterinary Medicine Author(s): Fields Shannon W
Nov/Dec 2006 Pg. 418	Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety Author(s): Fields Shannon W
Nov/Dec 2006 Pg. 421-424	Taurine for the Treatment of Canine Dilated Cardiomyopathy Author(s): Vail Jane
Nov/Dec 2006 Pg. 452	Amiloride Hydrochloride 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 324-328	Topical Cidofovir for Treatment of Resistant Viral Infections Author(s): McElhiney Linda F
Sep/Oct 2006 Pg. 336-342	Dermatological Effects from Years in the Sun: Compounding Opportunities Author(s): Jones Marty
Sep/Oct 2006 Pg. 351	Case Report: Treatment of Migraines with Compounded Piroxicam Mini-Troches Author(s): Williams Steve D
Sep/Oct 2006 Pg. 392-395	In Vitro Transdermal Diffusion of Zileuton from a Topical Gel Author(s): Bigeleisen Paul E
Sep/Oct 2006 Pg. 396-399	Temozolomide Stability in Extemporaneously Compounded Oral Suspensions Author(s): Trissel Lawrence A, Zhang Yanping, Koontz Susannah E
Jul/Aug 2006 Pg. 270-275	Compounded Treatment Options for Cystitis and Other Bladder Problems Author(s): McElhiney Linda F
Jul/Aug 2006 Pg. 288-290	Hospice Symptom Relief Kit: An Update Author(s): Petrin Ronald L
Jul/Aug 2006 Pg. 299	Adderall 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 300	Dapsone 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 301	Itraconazole 40-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 302	Lisinopril 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 303	Nifedipine 4-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 304	Propranolol Hydrochloride 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 306	Sildenafil Citrate 2.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 307	Tramadol Hydrochloride 5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 308	Tramadol Hydrochloride 7.5-mg/mL and Acetaminophen 65-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 316-317	Stability of Memantine in an Extemporaneously Prepared Oral Liquid Author(s): Yamreudeewong Weeranuj, Teixeira M Glaucia, Mayer Gabriele E
May/Jun 2006 Pg. 165-171	Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate Author(s): Reed-Kane Dana, Kirshbaum Karen
May/Jun 2006 Pg. 202-204	Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns? Author(s): Tran Tuan, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2006 Pg. 205-207	Basics of Compounding for Dentistry, Part 2: Tooth Whitening Author(s): Fonseca Simonne C
May/Jun 2006 Pg. 229	Triamcinolone Acetonide 0.1% Mouthwash Solution Author(s): Allen Loyd V Jr
Mar/Apr 2006 Pg. 147-153	Initial Selection of Antiemetics in End-of-Life Care: A Retrospective Analysis Author(s): Tolen Laura, McMath Jill A, Alt Calvin, Weschules Douglas J, Knowlton Calvin H, McPherson Mary Lynn
Mar/Apr 2006 Pg. 95-98	ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient Author(s): Moon Richard B
Mar/Apr 2006 Pg. 122-127	Basics of Compounding for Dentistry, Part 1: Effective Approaches and Formulations Author(s): Fonseca Simonne C
Jan/Feb 2006 Pg. 9-11	Levorphanol, Methadone, and the Management of Intractable Chronic Pain: An Interview with Kerry Schmidt, BA, MBA; Jack P. McNulty, MD, FACP; and George B. Muller, RPh Author(s): Vail Jane
Jan/Feb 2006 Pg. 14-18 View Sample	Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery Author(s): Heim Bob
Jan/Feb 2006 Pg. 59	Chlorambucil 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2006 Pg. 60	Dantrolene Sodium 5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2006 Pg. 61	Domperidone 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2006 Pg. 62	Efavirenz 20-mg/mL Oral Liquid, Anhydrous Author(s): Allen Loyd V Jr
Jan/Feb 2006 Pg. 63	Medium-Chain Triglycerides Oral Vehicle, Anhydrous Author(s): Allen Loyd V Jr
Jan/Feb 2006 Pg. 64	Mercaptopurine 50-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2006 Pg. 65	Misoprostol 1-mg Suppository Author(s): Allen Loyd V Jr
Jan/Feb 2006 Pg. 66	Naratriptan Hydrochloride 0.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2006 Pg. 67	Propylthiouracil 5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2006 Pg. 68	Thioguanine 40-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 410	Prescription: Pediatric Formulation Initiatives Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 413-420	Unlocking Autism: Is Compounding the Key? Author(s): Vail Jane
Nov/Dec 2005 Pg. 423-431	Compounding for a Pediatric Hospital Author(s): McElhiney Linda F
Nov/Dec 2005 Pg. 433-434 View Sample	Wiping Out Diaper Rash Author(s): Fields Shannon W
Nov/Dec 2005 Pg. 437-442	Pediatric Oral Liquid Preparations Author(s): Fonseca Simonne C, Ferreira Anderson de O
Nov/Dec 2005 Pg. 472	Alprazolam 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 473	Bethanechol 5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 474	Clonazepam 0.1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 475	Dolasetron 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 476	Ganciclovir 100-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 477	Isradipine 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 456-461	Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions Author(s): Fonseca Simonne C
Nov/Dec 2005 Pg. 462-469	Quality Control Analytical Methods: Quality Issues Related to Compounding with Commercial Products Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 478	Pyrazinamide 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 479	Quinidine Sulfate 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 480	Ursodiol 25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 481	Valganciclovir Hydrochloride 60-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 484-486	Chemical Stability of Perphenazine in Oral Liquid Dosage Forms Author(s): Gupta Vishnu D
Sep/Oct 2005 Pg. 354	A Patient's Guide to Transdermal Treatment of Pain Author(s): Fields Shannon W
May/Jun 2005 Pg. 178-182 View Sample	Update on Transdermals for Animal Patients Author(s): Davidson Gigi S
May/Jun 2005 Pg. 215-218	Basics of Compounding for Hair Care -- Part 2: Medicated Conditions Author(s): Fonseca Simonne C
May/Jun 2005 Pg. 242-246	Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study Author(s): Glisson James K, Wood Rebecca L, Kyle Patrick B, Cleary John D